How can we help?
Avoid blind spots in your market. Get the insights you need to accelerate innovation.
Los Angeles, CA January 3, 2019 – The end the last decade deepened my personal belief that the personalized medicine revolution will be driven by tools and diagnostics, rather than drugs. Taking consulting work out of the equation, here are the 10 topics that I spent time discussing often extemporaneously with my distinguished friends in the industry in 2019!
There has been other obvious discussion topics, including long read vs. short read sequencing, real-world evidence, CAR-T, or determinism / freewill. Wish you all a Happy New Year! Very much looking forward to more exciting discussions in 2020! #NGSisUnstoppable
Author: Stephane Budel, Partner at DeciBio Consulting, LLC
Connect with Stephane Budel on Linkedin
Disclaimer: Companies listed above may be DeciBio clients and/or customers